Friederike Windisch is a Senior Health Expert at the Pharmacoeconomics Department at Gesundheit Österreich GmbH / Austrian National Public Health Institute. She graduated from the University of Applied Management Sciences Krems, Austria, where she studied Health Management with focus on Pharmaceutical Management, Hospital Management and Insurance Management, and she is currently working on her PhD at the Vienna University of Economics and Business Administration, Austria, on pricing and reimbursement of medical devices. She also obtained a degree in Nutrition Science and worked for a Viennese hospital.
Since 2004, Ms Windisch has been working for the Austrian National Public Health Institute where she is involved in surveying and comparing price information of pharmaceuticals in the European Union. She is project manager of the Austrian Medical Devices Register (www.medizinprodukteregister.at) and of two EU4Health projects on medical devices (Study supporting the monitoring of availability of medical devices on the EU market, Study on the implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market).
Ms Windisch also manages the Pharmaceutical Pricing and Reimbursement Information (PPRI) subgroup on medical devices, which is an international network of competent authorities for medical devices to exchange information on pricing and reimbursement policies and to increase transparency in this field.

Maximilian Salcher-Konrad s a Senior Health Expert and the Deputy Head of the Pharmacoeconomics department at Gesundheit Österreich GmbH / Austrian National Public Health Institute. He conducts applied pharmaceutical policy research on pricing, reimbursement, and procurement of medicines. He holds an MSc in Health Policy, Planning and Financing from the London School of Economics and Political Science (LSE) and the London School of Hygiene and Tropical Medicine, and a BSc in Economics from the Vienna University of Economics and Business (WU). He has previously worked as a Research Fellow at the LSE, where he conducted research on comparative effectiveness of health interventions, methodological aspects of comparative effectiveness research and pharmaceutical policy, pharmaceutical regulation, and economic evaluation. Maximilian has a track record of leading and publishing original studies, systematic reviews and meta-analyses, including on the comparative effectiveness of interventions and mapping how evidence is generated in different research areas.